Search hospitals

>

Arkansas

>

Little Rock

University of Arkansas for Medical Sciences

Claim this profile

Little Rock, Arkansas 72205

Global Leader in Breast Cancer

Global Leader in Cancer

Conducts research for Lung Cancer

Conducts research for Multiple Myeloma

Conducts research for Ovarian Cancer

843 reported clinical trials

64 medical researchers

Photo of University of Arkansas for Medical Sciences in Little RockPhoto of University of Arkansas for Medical Sciences in Little RockPhoto of University of Arkansas for Medical Sciences in Little Rock

Summary

University of Arkansas for Medical Sciences is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Multiple Myeloma, Ovarian Cancer and other specialties. University of Arkansas for Medical Sciences is involved with conducting 843 clinical trials across 1,074 conditions. There are 64 research doctors associated with this hospital, such as Richard D. Hall, Heather Williams, MD, Rangaswamy Govindarajan, and V. S. Klimberg.

Area of expertise

1

Breast Cancer

Global Leader

University of Arkansas for Medical Sciences has run 67 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
ER positive
HER2 negative
2

Cancer

Global Leader

University of Arkansas for Medical Sciences has run 64 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage I

Top PIs

Clinical Trials running at University of Arkansas for Medical Sciences

Cervical Cancer

Lung Cancer

Breast Cancer

Prostate Cancer

Breast cancer

Ovarian Cancer

Melanoma

Oropharyngeal Carcinoma

Cancer

Testicular cancer

Image of trial facility.

Pembrolizumab + Chemotherapy

for Cervical Cancer

This phase III trial compares the addition of induction chemotherapy, with carboplatin, paclitaxel and pembrolizumab, to chemotherapy and radiation, with cisplatin and pembrolizumab followed by pembrolizumab maintenance for the treatment of patients with cervical cancer that has spread to nearby tissue or lymph nodes (locally advanced). Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Adding induction chemotherapy to the usual treatment of chemotherapy and radiation followed by maintenance may be more effective in treating patients with high risk, locally advanced cervical cancer.

Recruiting

2 awards

Phase 3

7 criteria

Image of trial facility.

PRGN-2009 + Pembrolizumab

for Cervical Cancer

This randomized trial will evaluate the efficacy and safety of PRGN-2009 in combination with pembrolizumab compared to pembrolizumab alone in patients with pembrolizumab-resistant recurrent or metastatic cervical cancer.

Recruiting

1 award

Phase 2

11 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Arkansas for Medical Sciences?

Where is University of Arkansas for Medical Sciences located?

Who should I call to ask about financial aid or insurance network?

What insurance does University of Arkansas for Medical Sciences accept?

What awards or recognition has University of Arkansas for Medical Sciences received?